Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Pulmonary Sarcoidosis by Nicotinic Acetylcholine Receptors

NCT00701207 is registered in ClinicalTrials.gov with Elliott Crouser MD as lead sponsor.

NCT NCT00701207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00701207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Pulmonary Sarcoidosis by Nicotinic Acetylcholine Receptors
Lead sponsor
Elliott Crouser MD
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2008
Completion date
December 31, 2010
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary sarcoidosis